Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 935 shares at $3.27 ($5K) on 2025-06-25, disclosed to the SEC on 2025-07-11.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 45 | $234 | 5.2% |
| 2 | $5.61 | 45 | $252 | 5.6% |
| 3 | $5.75 | 45 | $259 | 5.7% |
| 4 | $5.46 | 45 | $246 | 5.4% |
| 5 | $5.57 | 45 | $251 | 5.6% |
| 6 | $5.94 | 45 |
| $267 |
| 5.9% |
| 7 | $6.00 | 45 | $270 | 6.0% |
| 8 | $5.57 | 45 | $251 | 5.6% |
| 9 | $5.67 | 45 | $255 | 5.7% |
| 10 | $5.81 | 45 | $261 | 5.8% |
| 11 | $5.32 | 45 | $239 | 5.3% |
| 12 | $5.61 | 45 | $252 | 5.6% |
| 13 | $5.52 | 45 | $248 | 5.5% |
| 14 | $5.29 | 45 | $238 | 5.3% |
| 15 | $4.61 | 45 | $207 | 4.6% |
| 16 | $3.91 | 45 | $176 | 3.9% |
| 17 | $3.27 | 45 | $147 | 3.3% |
| 18 | $2.71 | 45 | $122 | 2.7% |
| 19 | $2.60 | 45 | $117 | 2.6% |
| 20 | $2.74 | 80 | $219 | 4.9% |
| Total | $4.83 avg | 935 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |
| CPIX | BUY | 2025-04-04 | $5K | — | Filing → |